Helsinki, Finland – Nanoform Finland Plc (“Nanoform”), the medicine performance-enhancing company, will host its Capital Markets Day Tuesday December 16th, 2025, in Helsinki at Nanoform’s headquarters and commercial cGMP manufacturing site.
At the event Nanoform’s leadership will present Nanoform’s key priorities for its next strategy period together with new business and financial targets. The event will include presentations by Edward Hæggström, CEO, Albert Hæggström, CFO, and Heads of Nanoform’s business areas and technologies. The event is expected to run for approximately four hours, with presentations beginning at 09.00 local time.
Nanoform’s Capital Markets Day is an In-Person event for investors, analysts, bankers and media. To participate in the event, attendees are asked to request a seat by e-mailing ir@nanoform.com. Seats are limited with priority for institutional investors.
Presentation materials and new mid-term targets for 2030 will be published December 16th, 2025, at 08 EEST / 07 CEST, and can be found on www.nanoform.com/en/investors/capital-markets-day-2025/. After the event, a transcript will be published on the same website.